ArticleJournal of cheminformatics2025
PURE: policy-guided unbiased REpresentations for structure-constrained molecular generation.
Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine-Learning-Driven Molecular Design and Structure-Property-Performance Relationships in Pharmaceutical Chemistry.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Structure-constrained molecular generation (SCMG) generates novel molecules that are structurally similar to a given molecule and have optimized properties. Deep learning solutions for SCMG are limited in that they are predisposed towards existing knowledge, and they suffer from a natural impedance mismatch problem due to the discrete nature of molecules, while deep learning methods for SCMG often operate in continuous space. Moreover, many task-specific evaluation metrics used during training often bias the model towards a particular metric -"metric-leakage". To overcome these shortcomings, we propose Policy-guided Unbiased REpresentations (PURE) for SCMG that learns within a framework simulating molecular transformations for drug synthesis. PURE combines self-supervised learning with a policy-based reinforcement learning (RL) framework, thereby avoiding the need for external molecular metrics while learning high-quality representations that incorporate an inherent notion of similarity specific to the given task. Along with a semi-supervised training design, PURE utilizes template-based molecular simulations to better explore and navigate the discrete molecular search space. Despite the lack of metric biases, PURE achieves competitive or superior performance to state-of-the-art methods on multiple benchmarks. Our study emphasizes the importance of reevaluating current approaches for SCMG and developing strategies that naturally align with the problem. Finally, we illustrate how our methodology can be applied to combat drug resistance by identifying sorafenib-like compounds as a case study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.